Management of Akathisia in Patients Taking Valproic Acid
For patients experiencing akathisia associated with valproic acid, the recommended approach is to lower the dosage of valproic acid, switch to another medication, add a benzodiazepine, or add a beta-adrenergic blocking agent such as propranolol. 1
Understanding Valproic Acid-Induced Akathisia
Akathisia is characterized by:
- Subjective feelings of inner restlessness and urge to move 2
- Objective manifestations including rocking while standing/sitting, lifting feet as if marching, and crossing/uncrossing legs 2
- Can be confused with restless legs syndrome but represents a distinct clinical entity 3
Valproic acid has been documented as a rare but definite cause of akathisia:
- Case reports confirm valproic acid can induce akathisia that resolves with drug cessation 3, 4
- May occur through a functional dopaminergic antagonism mechanism 4
Management Algorithm
First-Line Approaches
Dose Reduction or Medication Switch
Add Beta-Blockers
Second-Line Approaches
- Add Benzodiazepines
Third-Line Approaches
- Consider Other Agents
Special Considerations
Monitoring for Other Adverse Effects
- Monitor for hepatotoxicity, which is a rare but serious adverse effect of valproic acid 5, 7
- Watch for thrombocytopenia, especially in patients with brain tumors on chemotherapy 5
Medication Replacement
- In some cases, complete discontinuation of valproic acid may be necessary 3
- When valproic acid is used for mood stabilization, alternative agents like lithium may be considered, though lithium itself has rarely been associated with akathisia 6
Clinical Pitfalls to Avoid
- Avoid misdiagnosing akathisia as agitation, anxiety, or non-compliance 2
- Do not confuse with restless legs syndrome, which has different clinical features and management 3
- Remember that akathisia can occur with valproic acid even without concomitant antipsychotic use 3, 4
Conclusion of Management
The management of valproic acid-induced akathisia should follow a stepwise approach, starting with dose reduction or medication switch, followed by beta-blockers, then benzodiazepines if needed. Complete resolution often occurs with discontinuation of valproic acid 3.